"New Protein Target Offers Hope in Halting Alzheimer's Progression"
Researchers at Mount Sinai have discovered a potential new method to treat Alzheimer's by targeting the plexin-B1 protein to improve plaque clearance in the brain. This breakthrough could slow or halt disease progression and opens new avenues for therapeutic strategies. The study emphasizes the role of reactive astrocytes and validates gene network models, marking a significant advance in Alzheimer's research.